United State

English

STAT News

STAT News

About: STAT delivers trusted and authoritative journalism about health, medicine, and the life sciences. Millions of new readers turned to us as we sounded the alarm early on about the Covid-19 pandemic. Our journalists go deep in tough-minded coverage of the business of making medicines, health tech, science, and public health.
Contact Us: Email: first.opinion@statnews.com
Up and down the ladder: The latest comings and goings

Up and down the ladder: The latest comings and goings

Readout Newsletter: Otsuka, Vera Therapeutics, GLP

Readout Newsletter: Otsuka, Vera Therapeutics, GLP

STAT Health News: NIH, FDA on AI, taurine benefits, Medicaid

STAT Health News: NIH, FDA on AI, taurine benefits, Medicaid

We're reading about GLP-1s and eye disease, EU pharma reforms

We're reading about GLP-1s and eye disease, EU pharma reforms

Otsuka bests Vera Therapeutics in kidney disease showdown

Otsuka bests Vera Therapeutics in kidney disease showdown

The astounding U.S. university impact on drug innovation

The astounding U.S. university impact on drug innovation

At-home sexual assault test kits come with legal, health risks

At-home sexual assault test kits come with legal, health risks

Republicans eye Medicare Advantage reform to help fund tax cuts

Republicans eye Medicare Advantage reform to help fund tax cuts

Readout LOUD podcast: FDA AI experiment, Novo trails in obesity

Readout LOUD podcast: FDA AI experiment, Novo trails in obesity

Budget bill puts doctors, and their lobbyists, in middle of tug

Budget bill puts doctors, and their lobbyists, in middle of tug

Taurine may not be anti-aging wonder many believe, study says

Taurine may not be anti-aging wonder many believe, study says

Study rethinks use of race in research at politically sensitive time

Study rethinks use of race in research at politically sensitive time

GLP-1 drugs may be linked to higher risk of eye disease: study

GLP-1 drugs may be linked to higher risk of eye disease: study

Readout Newsletter: Novo Nordisk, Vigil, Merck, RegenxBio

Readout Newsletter: Novo Nordisk, Vigil, Merck, RegenxBio

STAT Health News: UnitedHealth, Novo Nordisk, Covid vaccines

STAT Health News: UnitedHealth, Novo Nordisk, Covid vaccines

STAT Health Tech: OpenEvidence's new JAMA deal, and more

STAT Health Tech: OpenEvidence's new JAMA deal, and more

We're reading about Novo Nordisk's caution, FDA approvals

We're reading about Novo Nordisk's caution, FDA approvals

MoonLake Immunotherapeutics is for sale? This sounds like a cry for help

MoonLake Immunotherapeutics is for sale? This sounds like a cry for help

NIH’s Human Genome Project archives are at risk of disappearing

NIH’s Human Genome Project archives are at risk of disappearing

Novo Nordisk led the weight loss drug boom. Now it's catch

Novo Nordisk led the weight loss drug boom. Now it's catch

Experts examine repercussions of Kennedy's Covid vaccine policy

Experts examine repercussions of Kennedy's Covid vaccine policy

Congress must save NIH’s global research partnerships

Congress must save NIH’s global research partnerships

UnitedHealth accidentally emails internal talking points to reporter

UnitedHealth accidentally emails internal talking points to reporter

Merck gets lift from patent office in battle over injectable Keytruda

Merck gets lift from patent office in battle over injectable Keytruda

Trump tax bill: Health care impact revealed in CBO report

Trump tax bill: Health care impact revealed in CBO report

Readout Newsletter: KJ CRISPR update, Vinay Prasad, ctDNA

Readout Newsletter: KJ CRISPR update, Vinay Prasad, ctDNA

How incarceration affects mortality — for people both inside and out

How incarceration affects mortality — for people both inside and out

AI Prognosis: FDA’s AI tool, Elsa, is here. 'Stupidest big fuss they ever made'

AI Prognosis: FDA’s AI tool, Elsa, is here. 'Stupidest big fuss they ever made'

We're reading about Merck eyeing a biotech, Moderna Covid

We're reading about Merck eyeing a biotech, Moderna Covid

Parents — and insurers — shouldn’t take RFK Jr.’s advice on vaccines

Parents — and insurers — shouldn’t take RFK Jr.’s advice on vaccines